Kaiser Permanente
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Kaiser Permanente sits in the top decile of US sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count).
Kaiser Permanente: 294 sponsored US clinical trials, 21 recruiting.
Kaiser Permanente sponsors 294 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 228 completed. 28 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 6 trials.
Top-decile sponsor footprint
Kaiser Permanente ranks in the top decile of sponsors by registered trial count (#117 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 238 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
294 total, page 2 of 6
Reduce IDentified UNcontrolled Asthma
NCT01449409
SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy
NCT01967030
STRIDE: Supporting Early Diabetes Self-Management for Parents
NCT07544407
Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure
NCT07467668
Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)
NCT07216859
Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation
NCT06710327
Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests
NCT06388694
Evaluation of a Patient 'nudge' on Engagement in Lung Cancer Screening
NCT06474611
Ultrasound-guided Transgluteal Sciatic Nerve Hydrodissection for the Treatment of Sciatica in the Emergency Department
NCT07588126
Pharmacist Management of Paxlovid eVisits
NCT06076863
Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?
NCT05359679
Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients
NCT06746714
Outreach to Reduce Depression Disparities
NCT05580406
Randomized Trial of HIFU vs. Cryo for Prostate Cancer
NCT06929065
COHERE - COntextualized Care in cHcs' Electronic Health REcords
NCT05022316
Randomized Pilot Study of a mHealth App for Ambivalent Smokers Living With HIV
NCT05339659
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
NCT05389397
Study of Colorectal Cancer Screening Options
NCT05987709
Bright Start Study
NCT05356130
Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2)
NCT04863872
Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study
NCT05059132
Food As Medicine Study
NCT05407376
Accelerating Implementation of Mindful Mood Balance for Moms
NCT04846504
Alcohol Telemedicine Consultation in Primary Care (ATC)
NCT05252221
Acupuncture for Chronic Low Back Pain in Older Adults
NCT04982315
Cancer Financial Experience
NCT05018000
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
NCT05073692
Leveraging Electronic Health Record Data in a Risk Prediction Model to Increase HIV PrEP Intake in Primary Care
NCT05991869
An Initial Study of the Implementation of Digital Therapeutics for Substance Use Disorders in Primary Care
NCT04907045
Michigan SPARC Trial
NCT04861792
A Randomized Control Trial of a Digital Health Tool
NCT05288517
Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients
NCT05096026
Adductor Canal Catheter Effectiveness and Safety Study
NCT04639128
Low-Dose Chest CT (LDCT) COVID-19 Study
NCT05031845
A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women
NCT03880461
Tailored Non-Pharmacotherapy Services for Chronic Pain
NCT04523714
Development of a mHealth Intervention for Ambivalent Smokers
NCT04560868
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675
Postpartum Wellness
NCT04414696
Reducing Treatment Risk in Older Adults With Diabetes
NCT04585191
Bundled Hyperpolypharmacy Deprescribing
NCT05616689
A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
NCT04505098
COVID-19 Antibody and Reinfection Study
NCT05365750
STAR Caregivers - Virtual Training and Follow-up
NCT04271046
Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk
NCT05166525
Meals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge
NCT04351880
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
NCT04246996
Evaluation of Anesthetic Techniques in Outpatient Total Joint Replacement Surgery in an Integrated Health Care Delivery System
NCT04203732
Performance Feedback in Health Care
NCT04579614
Predicting and Addressing Colonoscopy in Safety Net Settings
NCT03925883
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 21 |
| Phase 3 | 20 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Kaiser Permanente pipeline
21 recruiting of 294 indexed (7% open); 228 completed (78%).
Phase mix: 28 late (III/IV) vs 27 early (I/II) (balanced across stages).
Top condition: Depression (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kaiser Permanente: open-pipeline peers nationwide
Peers matched on 294 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Kaiser Permanente sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 294 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Mannkind Corporation · 7% recruiting · 42 trials
- Minneapolis Veterans Affairs Medical Center · 7% recruiting · 28 trials
Related
What to do with this Kaiser Permanente page
294 registered trials is a research-attention snapshot, not an endorsement of Kaiser Permanente or any single study.
- 21 of Kaiser Permanente's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Kaiser Permanente studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Kaiser Permanente pipeline card: 294 registered trials from official public datasets.Report a data error.